眼科

订阅

MedSci主页 / 所有栏目 / 眼科

ARVO 2016：低水平的维生素D与非感染性葡萄膜炎的发生有关

2016-05-08 MedSci MedSci原创

维生素D葡萄膜炎
关注

ARVO 2016：低水平的维生素D与非感染性葡萄膜炎的发生有关在今年的视觉与眼科研究协会(AEVO)年会上展示的一项新的研究表明,与未患有非感染性葡萄膜炎的研究对象相比，非感染性葡萄膜炎患者的维生素D的水平较低。会议上，Lindsay Grotting博士说道，“鉴于非感染性葡萄膜炎是由免疫功能紊乱所致，本研究旨在确定维生素D的水平是否与其发生有关。”该项回顾性研究共纳入了53名非感染性葡萄膜炎

在今年的视觉与眼科研究协会(AEVO)年会上展示的一项新的研究表明,与未患有非感染性葡萄膜炎的研究对象相比，非感染性葡萄膜炎患者的维生素D的水平较低。

会议上，Lindsay Grotting博士说道，“鉴于非感染性葡萄膜炎是由免疫功能紊乱所致，本研究旨在确定维生素D的水平是否与其发生有关。”

该项回顾性研究共纳入了53名非感染性葡萄膜炎患者和50名对照者。从麻省眼耳科医院的电子医疗记录记忆Uveitis数据库获得患者的数据资料。患者的平均年龄为66.5岁。

结果发现，非感染性葡萄膜炎患者的平均维生素D水平为26.2纳克/毫升，而对照组人群则为35.7纳克/毫升。

在单因素分析中发现，维生素D的水平每增加一个单位，非感染性葡萄膜炎的发生几率降低6%。校正年龄、性别、种族、服用维生素D补充剂史后，仍可发现维生素D的水平与非感染性葡萄膜炎的发生之间具有关联。

最后Grotting说道，“我们的研究结果表明，在非感染性葡萄膜炎的治疗上，除了目前的治疗方法之外，维生素D是一种低成本低副作用的治疗方法。但是，仍需要前瞻性的研究来充分阐明维生素D及其补充剂在葡萄膜炎发生过程中的作用。”

原始出处：

Nhu Te. Lower levels of vitamin D associated with increased risk of noninfectious uveitis. Healio, May 3, 2016.

Grotting L, et al. Association of vitamin D levels with noninfectious uveitis. Presented at: ARVO; May 1-5, 2016; Seattle, Washington.

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1819417, encodeId=7401181941ec8, content=<a href='/topic/show?id=802299441f5' target=_blank style='color:#2F92EE;'>#非感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99441, encryptionId=802299441f5, topicName=非感染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Sun Jul 17 19:03:00 CST 2016, time=2016-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655346, encodeId=e431165534697, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Tue Aug 23 05:03:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993312, encodeId=763e1993312a5, content=<a href='/topic/show?id=b2f1280466' target=_blank style='color:#2F92EE;'>#ARVO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2804, encryptionId=b2f1280466, topicName=ARVO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 21 20:03:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=126748, encodeId=e288126e485d, content=文章不错，值得拜读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 14 14:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661425, encodeId=f4011661425f8, content=<a href='/topic/show?id=ad519944261' target=_blank style='color:#2F92EE;'>#非感染性葡萄膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99442, encryptionId=ad519944261, topicName=非感染性葡萄膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ed25283281, createdName=124984e7m91暂无昵称, createdTime=Wed Jul 20 12:03:00 CST 2016, time=2016-07-20, status=1, ipAttribution=)]
    2016-07-17 xlwang2691

    #非感染性#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1819417, encodeId=7401181941ec8, content=<a href='/topic/show?id=802299441f5' target=_blank style='color:#2F92EE;'>#非感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99441, encryptionId=802299441f5, topicName=非感染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Sun Jul 17 19:03:00 CST 2016, time=2016-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655346, encodeId=e431165534697, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Tue Aug 23 05:03:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993312, encodeId=763e1993312a5, content=<a href='/topic/show?id=b2f1280466' target=_blank style='color:#2F92EE;'>#ARVO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2804, encryptionId=b2f1280466, topicName=ARVO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 21 20:03:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=126748, encodeId=e288126e485d, content=文章不错，值得拜读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 14 14:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661425, encodeId=f4011661425f8, content=<a href='/topic/show?id=ad519944261' target=_blank style='color:#2F92EE;'>#非感染性葡萄膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99442, encryptionId=ad519944261, topicName=非感染性葡萄膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ed25283281, createdName=124984e7m91暂无昵称, createdTime=Wed Jul 20 12:03:00 CST 2016, time=2016-07-20, status=1, ipAttribution=)]
    2016-08-23 charl1234575

    #感染性#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1819417, encodeId=7401181941ec8, content=<a href='/topic/show?id=802299441f5' target=_blank style='color:#2F92EE;'>#非感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99441, encryptionId=802299441f5, topicName=非感染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Sun Jul 17 19:03:00 CST 2016, time=2016-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655346, encodeId=e431165534697, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Tue Aug 23 05:03:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993312, encodeId=763e1993312a5, content=<a href='/topic/show?id=b2f1280466' target=_blank style='color:#2F92EE;'>#ARVO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2804, encryptionId=b2f1280466, topicName=ARVO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 21 20:03:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=126748, encodeId=e288126e485d, content=文章不错，值得拜读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 14 14:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661425, encodeId=f4011661425f8, content=<a href='/topic/show?id=ad519944261' target=_blank style='color:#2F92EE;'>#非感染性葡萄膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99442, encryptionId=ad519944261, topicName=非感染性葡萄膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ed25283281, createdName=124984e7m91暂无昵称, createdTime=Wed Jul 20 12:03:00 CST 2016, time=2016-07-20, status=1, ipAttribution=)]
    2016-09-21 12498da4m32(暂无昵称)

    #ARVO#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1819417, encodeId=7401181941ec8, content=<a href='/topic/show?id=802299441f5' target=_blank style='color:#2F92EE;'>#非感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99441, encryptionId=802299441f5, topicName=非感染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Sun Jul 17 19:03:00 CST 2016, time=2016-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655346, encodeId=e431165534697, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Tue Aug 23 05:03:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993312, encodeId=763e1993312a5, content=<a href='/topic/show?id=b2f1280466' target=_blank style='color:#2F92EE;'>#ARVO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2804, encryptionId=b2f1280466, topicName=ARVO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 21 20:03:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=126748, encodeId=e288126e485d, content=文章不错，值得拜读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 14 14:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661425, encodeId=f4011661425f8, content=<a href='/topic/show?id=ad519944261' target=_blank style='color:#2F92EE;'>#非感染性葡萄膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99442, encryptionId=ad519944261, topicName=非感染性葡萄膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ed25283281, createdName=124984e7m91暂无昵称, createdTime=Wed Jul 20 12:03:00 CST 2016, time=2016-07-20, status=1, ipAttribution=)]
    2016-09-14 1e10c84am36(暂无匿称)

    文章不错，值得拜读

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1819417, encodeId=7401181941ec8, content=<a href='/topic/show?id=802299441f5' target=_blank style='color:#2F92EE;'>#非感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99441, encryptionId=802299441f5, topicName=非感染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Sun Jul 17 19:03:00 CST 2016, time=2016-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655346, encodeId=e431165534697, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Tue Aug 23 05:03:00 CST 2016, time=2016-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1993312, encodeId=763e1993312a5, content=<a href='/topic/show?id=b2f1280466' target=_blank style='color:#2F92EE;'>#ARVO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2804, encryptionId=b2f1280466, topicName=ARVO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Sep 21 20:03:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=126748, encodeId=e288126e485d, content=文章不错，值得拜读, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 14 14:52:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661425, encodeId=f4011661425f8, content=<a href='/topic/show?id=ad519944261' target=_blank style='color:#2F92EE;'>#非感染性葡萄膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99442, encryptionId=ad519944261, topicName=非感染性葡萄膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ed25283281, createdName=124984e7m91暂无昵称, createdTime=Wed Jul 20 12:03:00 CST 2016, time=2016-07-20, status=1, ipAttribution=)]
    2016-07-20 124984e7m91暂无昵称

    #非感染性葡萄膜炎#

    0

相关资讯

PLOS ONE：提高维生素D水平可降低癌症风险

高维生素D水平可使癌症风险降低超过65%，该研究结果于4月6日发表在PLOS ONE。上述结果来自一项随机试验和一项前瞻性队列研究的汇合分析，较高的维生素D水平是指25-羟维生素D水平超过40ng/ml。“较高的25-羟维生素D浓度与包括乳腺癌、结肠癌、肺癌等在内的多种癌症风险降低有关。” 加州大学圣地亚哥分校医学院穆尔斯癌症中心公共卫生学博士Cedric Garland说道。“我和我的已故的哥哥

Pediatric Obesity：婴儿期补充维生素D可增加儿童3岁时的肌肉量

Pediatric Obesity：婴儿期补充维生素D可增加儿童3岁时的肌肉量目前对于维生素D对身体成分的影响尚未清楚。来自加拿大的一项研究探究了婴儿时期补充维生素D是否会影响儿童3 岁时的身体组分，其结果表明婴儿时期至3岁时高水平的维生素D可增加机体的肌肉量减少脂肪量，该研究成果已在线发表于Pediatric Obesity。采用随机双盲试验设计，共纳入了132名1月龄的健康婴儿，均为母乳喂养，

JACC：补充维生素D3可改善慢性心衰患者心功能(VINDICATE研究)

近年来维生素D已被誉为神奇的维生素,因为它其具有预防机体患慢性疾病如癌症、骨质疏松、心脏病,阿尔茨海默症等疾病的作用，促使民众保持身心健康。 英国研究人员进行的一项研究表明，日常补充维生素D有助于改善慢性心功能衰竭患者的身体状况。利兹大学的研究人员发现，维生素D3有助于改善慢性心力衰竭患者的心功能。研究结果在美国心脏病学会第65届年度科学会议上提出。 在他们的研究中,以Klaus Witte博士为

ACC 2016：机体维生素D水平可预测心血管病发病风险

心血管研究所的流行病学家Heidi May博士指出，可通过检测机体维生素D2和维生素D3的水平评估民众发生心脏病、卒中、心衰和其他心血管疾病的风险。他和同事们发现,相比维生素D水平正常的民众而言，维生素D含量和利用率都较低的民众更易发生心血管疾病。可利用维生素D是指被吸收入血且不与周围蛋白质结合的维生素D。研究人员将研究结果在美国心脏病学会科学会议上提出。 May博士和同事对年龄为52-76岁共4

Am J Gastroenterol：缺乏维生素D会增加NAFLD患者的NASH风险

近期发表在American Journal of Gastroenterology的研究称，维生素D缺乏会增加非酒精性脂肪肝（NAFLD）患者的非酒精性脂肪肝炎（NASH）风险。西雅图瑞典医疗中心从事肝脏研究的Kris V. Kowdley博士和同事写道：“近期的研究表明，缺乏维生素D会增加氧化应激和系统性炎症，降低脂联素水平、toll样受体激活和NAFLD...我们对NAFLD患者进行了一项研究

PLoS ONE：提高维生素D水平可有效预防癌症的发生

有研究显示增加人体血液中维生素D的含量可能成为一种预防癌症的重要手段，因为他们的研究发现随着维生素D水平的下降，癌症的发生率将大大提高。 PLos One杂志中，来自加州大学 - 圣地亚哥分校（UCSD）医学院的研究人员报道了他们是如何分析维生素D与癌症的联系，以确定什么样的血液维生素D水平对有效降低患癌症风险是必需的。 这项研究包括了除皮肤癌之外其他所有的恶性肿瘤。 该论文的作者之一，